BRIC
View Older Stories View More Recent Stories
-
BrickBio Debuts Powerful Advantage of Novel ADCs, Protein Origami, and Synthetic Virology at 2022 AACR
-
Form D Las Olas Capital - BRIC
-
Mayville Engineering Company Inc. (MEC) Announces Retirement Plan of CEO Robert D. Kamphuis
-
Brickless Developers Group Launches Construction on Virtual World of Metaverse and Reality
-
Brickell City Centre Continues Momentum with Nine New Tenants
-
Brick & Mortar: Better Than Ever.
-
Four weeks of war scar Russia's economy
-
Tantalus Systems Holding Inc. Reports Financial Results for Fourth Quarter and Fiscal 2021
-
Brickell Biotech Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
-
Brickell Biotech Selected for a Late-Breaking Oral Presentation of US Phase 3 Pivotal Cardigan I and Cardigan II Study Results for Sofpironium Bromide Gel, 15% at the 2022 AAD Annual Meeting
-
The Brooklyn Tower Launches Sales for the Borough's Highest Condominium Residences
-
Brickell Biotech to Report Fourth Quarter and Full Year 2021 Financial Results and Provide a Corporate Update on March 15, 2022
-
Brickworks Celebrates Global Flagship Design Studio in New York City
-
BrickSeek Debuts Its Mobile Shopping App for Deals On-Demand
-
Tantalus Systems Announces 2021 Business Highlights with Strong Momentum Heading into 2022
-
Brickworks North America Corporation Expands Direct Distribution Network with the Bolt-On Acquisition of Long-Established Washington D.C. Masonry Supplier, Capital Brick
-
Brickell Biotech (BBI) Acquires Exclusive Global Rights to Portfolio of Novel STING Inhibitors Targeting Autoimmune and Inflammatory Diseases from Carna Biosciences
-
Brickell Biotech Acquires Exclusive Global Rights to Portfolio of Novel STING Inhibitors Targeting Autoimmune and Inflammatory Diseases from Carna Biosciences
-
Bricz, A Leading Supply Chain Solutions Provider, Announces Rebrand and Expands Solution Offerings
-
Brick Street Realty Partners With Side To Grow Its Loyal Client Base
-
IAPMO Supports Passage of Federal Infrastructure Legislation
-
Brickworks Expands North American Footprint with New Design Studio in Baltimore
-
National Association of Chronic Disease Directors Announces Launch of the Center for Advancing Healthy Communities
-
Brickell Biotech Reports Third Quarter 2021 Financial Results and Provides Corporate Update
-
MTC, ABAG Leaders Applaud Passage of New Infrastructure Bill
-
Brick by Brick Capital Acquires Historic Four Seasons Island Resort in Pembine, Wisconsin in Partnership with Life House
-
Canada Ranks 10th for Retiree Wellbeing in Natixis Investment Managers’ 2021 Global Retirement Index as Savers Hope for a Miracle
-
BrickBio Announces Rapid V2, eCLIC™, Chemistry and Cytokine External Partner Collaboration
-
The Brooklyn Tower at 9 DeKalb Tops Out--Taking the Crown as Brooklyn's First Supertall Skyscraper
-
Brickell Biotech to Report Third Quarter 2021 Financial Results and Provide a Corporate Update on November 9, 2021
-
Thompson Central Park New York Debuts in Midtown Manhattan
-
Brickell Biotech (BBI) Prices 26.3M Share Offering at $0.38/sh
-
Brickell Biotech Prices Public Offering of Common Stock
-
Brickell Biotech (BBI) Announces Proposed Underwritten Public Offering of Common Stock
-
Brickell Biotech Announces Proposed Underwritten Public Offering of Common Stock
-
Reservoir Signs Singer-Songwriter Madison McFerrin to a Worldwide Admin Deal
-
Webtel.mobi Describes Why the High Debt of G7 Countries is a Likely Barrier to Global CBDC and Digital Currency Adoption
-
Webtel.mobi Describes Why the High Debt of G7 Countries is a Likely Barrier to Global CBDC and Digital Currency Adoption
-
Brickell Biotech (BBI) Achieves Statistical Significance on all Primary, Secondary Endpoints from Both U.S. Phase 3 Pivotal Studies of Sofpironium Bromide Gel, 15% in Primary Axillary Hyperhidrosis
-
Brickell Biotech Announces Positive Topline Results, Achieving Statistical Significance on all Primary and Secondary Endpoints, from Both U.S. Phase 3 Pivotal Clinical Studies of Sofpironium Bromide G
-
Brickell Biotech to Host Key Opinion Leader Webinar on DYRK1A and its Role in Autoimmunity
-
United States Ranks 17th for Retiree Wellbeing in Natixis Investment Managers’ 2021 Global Retirement Index as Savers Hope for a Miracle
-
Ari Lennox Salutes Her Favorite Iconic Divas With New Riveting Video "Pressure"
-
Brickell Biotech to Participate at Upcoming September Conferences
-
DAX welcomes ten new members
-
Brickell Biotech Expands Leadership Team, Appointing Dr. Monica Luchi as Chief Medical Officer
-
Brickell Biotech (BBI) Acquires Exclusive Rights to Phase 1-Ready DYRK1A Inhibitor Program and Novel Platform
-
Brickell Biotech Acquires Exclusive Rights to Phase 1-Ready DYRK1A Inhibitor Program and Novel Platform Targeting Autoimmune and Inflammatory Diseases
-
Brickell Biotech Announces Final Patient Completed Second U.S. Phase 3 Pivotal Clinical Study of Sofpironium Bromide Gel, 15% for the Treatment of Primary Axillary Hyperhidrosis
-
Brickell Biotech Reports Second Quarter 2021 Financial Results and Provides Corporate Update

